Revenue: The sum of all revenue fields included for a company's operating activities.
BioNTech SE Sponsored ADR (BNTX) had Revenue of $2.98B for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$2.98B |
$-719.92M |
|
$585.74M |
|
$2.39B |
|
$4.40B |
|
$-1.42B |
|
$688.86M |
|
$-733.34M |
|
$-733.34M |
|
$-719.92M |
|
$-719.92M |
|
$-719.92M |
|
$-719.92M |
|
$-1.42B |
|
$-1.10B |
|
240.40M |
|
240.40M |
|
$-3.00 |
|
$-3.00 |
|
| Balance Sheet Financials | |
$20.35B |
|
$1.01B |
|
$4.03B |
|
$24.38B |
|
$2.73B |
|
$232.33M |
|
$644.28M |
|
$3.37B |
|
$21.00B |
|
$19.74B |
|
$21.00B |
|
239.97M |
|
| Cash Flow Statement Financials | |
$224.75M |
|
$-2.25B |
|
$-49.67M |
|
$12.62B |
|
$10.56B |
|
$-2.06B |
|
$-58.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.45 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
80.32% |
|
-47.77% |
|
-47.77% |
|
-36.94% |
|
-24.63% |
|
-24.18% |
|
$-83.97M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
1.91 |
|
1.82 |
|
200.86 |
|
-3.43% |
|
-3.65% |
|
-2.95% |
|
-3.39% |
|
$87.53 |
|
$-0.35 |
|
$0.93 |
|